[Antinuclear antibodies in pulmonary diseases].
D000974:Antibodies, Antinuclear / Q000032:analysis*; D000917:Antibody Formation; D001194:Asbestos; D001195:Asbestosis / Q000276:immunology*; D001249:Asthma / Q000276:immunology*; D002464:Cell Migration Inhibition; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D008214:Lymphocytes; D011658:Pulmonary Fibrosis / Q000276:immunology* / Q000473:pathology / Q000628:therapy
D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D001194:Asbestos
Anticorps antinucléaires dans les maladies pulmonaires.